⌘K

Home/Filings/4/0000950170-24-009805

4//SEC Filing

Cavalier Jason 4

Accession 0000950170-24-009805

CIK 0001327273other

View on SEC.gov Company Profile

Filed

Jan 31, 7:00 PM ET

Accepted

Feb 1, 4:15 PM ET

Size

5.6 KB

Accession

0000950170-24-009805

Insider Transaction Report

Form 4

Period: 2024-01-30

Lyra Therapeutics, Inc.LYRA

Chief Financial Officer

Transactions

Award
Stock Options
2024-01-30+200,000→ 200,000 total
Exercise: $4.58Exp: 2034-01-29→ Common Stock (200,000 underlying)

Footnotes (1)

[F1]This option vests and becomes exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following January 30, 2024.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Lyra Therapeutics, Inc.

CIK 0001327273

Entity typeother

Related Parties

1

filerCIK 0001883290

Filing Metadata

Form type: 4
Filed: Jan 31, 7:00 PM ET
Accepted: Feb 1, 4:15 PM ET
Size: 5.6 KB

View on SEC.gov